Idenix Pharmaceuticals To Present at the Bear Stearns Biotech Confab and the Goldman Sachs 28th Annual Global Healthcare Confere

CAMBRIDGE, Mass., May 29  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the upcoming Bear Stearns Biotech Confab on Thursday, June 7th at 2:30 p.m. (EDT) in Boston and at the Goldman Sachs 28th Annual Global Healthcare Conference on Tuesday, June 12th at 11:00 a.m. (PDT) in Laguna Niguel, CA.

The live and archived webcasts of the presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. Please log in approximately 5-10 minutes before the events to ensure a timely connection.  The archived replays will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV).  For further information about Idenix, please refer to http://www.idenix.com/. 

DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT:  media, Teri Dahlman [phone], or investors, Amy

Sullivan, [phone], both of Idenix Pharmaceuticals, Inc. 



Web site:  http://www.idenix.com/

Copyright